4Jusus Valle MJ,Lopez FG,Navarro AS. Development and vali-dation of an HPLC method for vancomycin application to a phar-macokinetic study [J].J Pharm Biomed Anal,2008,48 (3):835-839.
8ZHANGYY.Treatment progress of gram-positive cocci infections .中国抗感染化疗杂志,2001,1(1):50-53.
9LUY SHUNJ ZHANGJ etal.Clinical rational analysis of monitoring results in serum concentrations of vancomycin in 340 cases .中国医院药学杂志,2007,27(5):649-650.
10LUXJ.Rational use of antibiotics .现代临床医学,2005,31(4):286-290.
7Rybak M,Lomaestro B, Hotschafer J Cyet al. Therapeutic monito-ring of vancomycin in adult patients : a consensus review of the A-merican Society of Health - System Pharmacists,the Infectious Dis-eases Society of America, and the Society of Infectious DiseasesPharmacists[ J]. Am J Health Syst Pharm, 2009 ; 66: 82-98.
10Rybak MJ, Lomaestro BM, Rotscahfer JC, et al. Vancomycin therapeutic guidelines:a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists [J].Clin Infect Dis,2009,49(3) :325.
